Back to News
Market Impact: 0.55

Starbucks (SBUX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

SBUXSPYNVDA
Corporate EarningsCompany FundamentalsAnalyst EstimatesAnalyst InsightsConsumer Demand & RetailMarket Technicals & Flows
Starbucks (SBUX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Starbucks (SBUX) reported Q4 revenue of $9.57 billion, surpassing the $9.33 billion consensus estimate by 2.61% and marking a 5.5% year-over-year increase. However, EPS came in at $0.52, missing the $0.55 estimate by 5.46% and significantly down from $0.80 a year ago. Despite the EPS miss, the company achieved positive global comparable store sales growth of 1%, exceeding analyst expectations, driven by International sales up 3% and North America sales flat at 0%. The stock has underperformed the S&P 500 recently and holds a Zacks Rank #4 (Sell), suggesting potential near-term underperformance.

Analysis

Starbucks (SBUX) reported Q4 revenue of $9.57 billion, exceeding the Zacks Consensus Estimate of $9.33 billion by 2.61% and marking a 5.5% year-over-year increase. However, EPS came in at $0.52, missing the $0.55 consensus estimate by 5.46% and representing a significant decline from $0.80 in the prior year. This mixed performance indicates top-line strength but bottom-line pressure. Despite the EPS miss, the company demonstrated resilience in comparable store sales, achieving a 1% year-over-year increase globally, surpassing the -0.1% analyst estimate. This was driven by a strong 3% growth in International comparable store sales, significantly above the 1.7% estimate, and North America comparable store sales remaining flat at 0%, outperforming the -0.7% estimate. These figures suggest robust underlying demand in key markets. Segmental revenues showed strong performance in North America company-operated stores ($6.28 billion vs $6.14 billion estimated) and International ($2.07 billion vs $2.04 billion estimated), both exceeding expectations. Conversely, licensed store revenues in North America and globally saw year-over-year declines and missed estimates. The stock has underperformed the broader market, returning only +1% over the past month compared to the S&P 500's +3.8%, and holds a Zacks Rank #4 (Sell), signaling potential near-term underperformance. This market reaction and analyst sentiment reflect the concern over the significant EPS decline despite revenue beats.